These growth stocks are highly profitable and evolving in their respective industries. Eli Lilly is famed for its weight-loss medications, but it is more than just a GLP-1 play. MercadoLibre is a ...
Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID-19, the debilitating ...
Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.
Get the latest S&P 500 healthcare stock winners & losers, major earnings beats, profit forecasts, and legal news for key companies.
Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.
In late October 2025, Point32Health, Massachusetts’ second-largest health insurer, announced its second major round of ...
With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback